Evolent Health, Inc. (NYSE: EVH), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced the pricing of a public offering of 8,816,120 shares of its Class A common stock at a public offering price of $19.85 per share. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 1,322,418 shares of Class A common stock. The offering is expected to close on August 14, 2017, subject to the satisfaction of customary closing conditions.
J.P. Morgan Securities LLC and Goldman Sachs & Co. LLC are acting as joint book-running managers and as representatives of the underwriters for the offering. Wells Fargo Securities, LLC, William Blair & Company, L.L.C. and SunTrust Robinson Humphrey, Inc. are acting as lead managers, and Leerink Partners LLC and Robert W. Baird & Co. Incorporated are acting as co-managers.
About Evolent Health
Evolent Health partners with leading provider organizations to achieve superior clinical and financial results in value-based care. With a provider heritage and over 20 years of health plan administration experience, Evolent operates in more than 30 U.S. health care markets, actively managing care across Medicare, Medicaid, commercial and self-funded adult and pediatric populations. With the experience to drive change, Evolent confidently stands by a commitment to achieve results. For more information, visit evolenthealth.com.